Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the Central Nervous System (CNS). Subjects 20-40 years old are affected in a relapsing-remitting, secondary progressive or primary progressive pattern. Although the clinical course of the disease is variable, it usually leads to progressive deterioration and severe disability. Both genetic and environmental factors have been implicated in the pathogenesis of MS. The precise cause remains largely unknown, but there is evidence of a myelin-antigen-specific, Th1-mediated immune process resulting in macrophage-mediated demyelination, axonal loss and gliosis. Multiple sclerosis has no cure at the time, however, treatments may help treat MS attacks, manage symptoms and reduce progress of the disease Vasiliki E. Kalodimou et al Multiple Sclerosis & Research.
Journal of Multiple Sclerosis is an open access peer reviewed journal started considering the specialised characteristics of this disease as well as its relevance in the field of multiple sclerosis research. The journal also publishes a gallery along with every issue of the journal including specialised images as well as videos based on various treatment styles and techniques and disease betterment.
Last date updated on October, 2020